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Abstract
A 62-year-old male with known prostate cancer underwent 18F-fluorodeoxyglucose positron emission tomography/
computed tomography (18F-FDG PET/CT) scan for suspected osseous metastases after a magnetic resonance imaging 
of the pelvis, done for chronic low back pain and demonstrated a number of suspicious T1 hypointense/T2 hyperintense 
lesions in the sacrum, iliac bones and right proximal femur.18F-FDG PET/CT showed abnormal foci of increased 
tracer uptake in the sacrum, iliac bones and right proximal femur. Core biopsies from the sacrum were performed, 
showing intertrabecular non-caseating granulomata with surrounding small lymphocytes. Acid-fast bacilli and Gomori 
methenamine silver stains were negative, consistent with intraosseous sarcoidosis.
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Introduction
Sarcoidosis is a chronic granulomatous multisystem 
disease, of unknown aetiology, which can affect any 
organ. In >90% of patients, clinical sarcoidosis manifests 
as intrathoracic lymph node enlargement, pulmonary 
involvement and skin or ocular signs and symptoms.[1] The 
natural course and history of sarcoidosis is unpredictable. 
Due to a variety of organ involvement, sarcoidosis often 
mimics other diseases.[2] Malignancy may develop in 
patients with sarcoidosis and patients with sarcoidosis 
may also develop cancer.[3]
Case Report
We report a case of a 62-year-old male with known locally 
advanced prostate cancer diagnosed approximately 7 years 
ago. It was initially treated with radiation therapy and 
androgen ablation.
The patient presented to us with a complaint of low 
back pain for the past 3 months. An magnetic resonance 
imaging (MRI) of the lumbar spine and pelvis was 
performed, which demonstrated a number of suspicious 
T1 hypointense and T2 hyperintense lesions in the iliac 
bones, sacrum and right proximal femur, suggestive of 
metastatic disease [Figure 1].
The patient was then referred to the Division of Nuclear 
Medicine at the University of Wisconsin for an18F-
fluorodeoxyglucose positron emission tomography/
computed tomography (18F-FDG PET/CT) scan, for 
suspected osseous metastases. A bone scan acquired 
6 months prior had shown no evidence of osseous 
metastatic disease.18F-FDG PET/CT showed abnormal 
foci of increased 
FDG uptake in the sacrum, iliac bones and right proximal 
femur [Figure 2] corresponding to the abnormal marrow 
signals seen in the pelvis and right proximal femur on 
MRI.
The scan also showed hypermetabolic bilateral mediastinal 
and hilar lymphadenopathy [Figure 2]. Core biopsies from 
the sacrum were performed and showed intertrabecular, 
non-caseating granulomata, with surrounding small 
lymphocytes. Acid-fast bacilli and Gomori methenamine 
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silver stains were negative, consistent with sarcoidosis 
[Figure 3].
Discussion
Sarcoidosis is a multisystem disease characterised by 
the formation of non-caseating granulomata, affecting 
different organs of the body, including lungs, skin, hilar 
lymph nodes, eyes and bone.[4,5] Osseous sarcoidosis is 
exceedingly rare and is difficult to establish since it may 
simulate metastatic disease.[6] Routine MRI studies also 
cannot reliably distinguish osseous sarcoidosis lesions 
from metastatic lesions as the MRI appearance closely 
resembles that of osseous metastases.[2,7] Histology, 
showing non-caseating granulomata remains the 
gold standard for diagnosis.[8] The bones are affected 
by sarcoidosis in 1–13% of patients, as osteolytic, 
osteoporotic or cystic lesions.[7,9] Bone sarcoidosis is most 
frequently found in the peripheral skeleton, for example, 
in the bones of the hands and feet.[7,9] The development of 
sarcoidosis and sarcoid-like reactions has been noted in 
cancer patients after antineoplastic therapy and even after 
surgery for cancer, without chemotherapy.[10,11] 18F-FDG 
PET/CT is commonly used today for staging, to assess 
response, to therapy and to diagnose the recurrence 
of malignancy. However, infectious or inflammatory 
processes also accumulate FDG and this can sometimes 
lead to diagnostic inaccuracy.[12] Increased FDG uptake is 
seen in sarcoidosis due to accumulation of inflammatory 
cells including neutrophils, activated macrophages and 
lymphocytes.[3] Serial 18F-FDG PET/CT scans can be 
used for the assessment of the activity of sarcoidosis and 
to assess the response to therapy.[1,13] Patients with diverse 
malignant neoplasms have been seen to develop new onset 
of previously undiagnosed sarcoidosis or the development 
of sarcoid-like reactions. This has been noted in patients 
with haematological malignancies as well as in patients 
with solid tumours.[14,15] Tumour-related sarcoid-like 
reactions are considered to be caused by soluble antigens 
derived from tumour cells.[16] Regarding the differential 
diagnosis of disseminated malignancies from sarcoidosis 
or sarcoid-like reactions, symmetrical hilar FDG uptake 
Figure 1: Unenhanced magnetic resonance imaging pelvis and 
femur showed T1 hypointense (a and c) and T2 hyperintense 
signal (b and d) in the iliac bone and right femur (arrows)
dc
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Figure 2: Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scan was performed 55 min 
after the administration of 9.3 mCi of F-18 FDG. Maximum intensity projection PET image (a) showed multiple foci of increased 
uptake including mediastinum and pelvis. The axial and coronal PET and fusion images (b-d) showed hypermetabolic lesions in the 
iliac bones, sacrum and right proximal femur (SUVmax up to 4.9) corresponding to signal abnormalities seen on the magnetic resonance 
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may be related to a benign cause as was seen in our 
patient. However, the caveat is that the characteristic 
hilar FDG uptake in patients with granulomatous disease 
can be similar to that in patients with metastatic disease. 
FDG-PET/CT is helpful in highlighting organs that are 
candidates for diagnostic biopsy.[17]
Conclusion
Osseous sarcoidosis is relatively rare and is a difficult 
diagnosis to establish due to its similarity to metastatic 
disease in oncologic patients. Histological diagnosis of 
non-caseating granulomata remains the gold standard 
for the diagnosis of sarcoidosis. Symmetric FDG 
uptake in hilar and/or mediastinal nodes is a typical 
finding in sarcoidosis and can help in making the 
correct diagnosis.18F-FDG PET/CT can be helpful in 
demonstrating FDG-avid lesions for biopsy.
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Figure 3: Core biopsies from the sacrum showed intertrabecular 
non-caseating granulomata with surrounding small lymphocytes. 
Acid-fast bacilli and Gomori methenamine silver stains were 
negative, consistent with sarcoidosis
